Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Who is buying the warrant conversions?
"At May 31, 2006, the Company had warrants outstanding to purchase 53,349,220 common shares"
From the 10k. Latest reported number on warrants outstanding was what, around 29m. I think you better re-check your calculation of 50m shares dumped for warrant conversion.
Share
New Message
Please login to post a reply